Nisa Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Sell
36,042
-7,427
-17% -$4.76M 0.07% 162
2025
Q4
$29.4M Buy
43,469
+5,215
+14% +$3.55M 0.1% 121
2025
Q3
$24.4M Sell
38,254
-1,912
-5% -$1.16M 0.09% 140
2025
Q2
$21.5M Sell
40,166
-52
-0.1% -$24.9K 0.1% 160
2025
Q1
$16.9M Buy
40,218
+169
+0.4% +$73.4K 0.08% 194
2024
Q4
$16.6M Sell
40,049
-2,845
-7% -$1.25M 0.06% 214
2024
Q3
$21.7M Buy
42,894
+50
+0.1% +$24.3K 0.13% 156
2024
Q2
$20.9M Sell
42,844
-1,030
-2% -$517K 0.13% 161
2024
Q1
$23.7M Sell
43,874
-686
-2% -$375K 0.15% 146
2023
Q4
$24.7M Buy
44,560
+2,701
+6% +$1.27M 0.18% 131
2023
Q3
$18.3M Buy
41,859
+543
+1% +$271K 0.14% 167
2023
Q2
$20.8M Sell
41,316
-2,194
-5% -$1.05M 0.15% 145
2023
Q1
$21.8M Sell
43,510
-301
-0.7% -$144K 0.17% 131
2022
Q4
$17.9M Buy
43,811
+1,447
+3% +$562K 0.14% 171
2022
Q3
$13.8M Sell
42,364
-564
-1% -$207K 0.12% 188
2022
Q2
$15.1M Buy
42,928
+1,003
+2% +$409K 0.13% 167
2022
Q1
$22.9M Sell
41,925
-8,714
-17% -$4.58M 0.16% 129
2021
Q4
$25.7M Sell
50,639
-13,537
-21% -$8.5M 0.19% 120
2021
Q3
$39.9K Buy
64,176
+353
+0.6% +$237K 0.24% 85
2021
Q2
$40.3K Sell
63,823
-2,886
-4% -$1.59M 0.25% 83
2021
Q1
$32.6K Sell
66,709
-7,401
-10% -$3.71M 0.21% 95
2020
Q4
$37M Sell
74,110
-41,336
-36% -$18.5M 0.24% 95
2020
Q3
$45.4M Buy
115,446
+56,963
+97% +$21.1M 0.37% 59
2020
Q2
$19.3M Buy
58,483
+349
+0.6% +$101K 0.18% 128
2020
Q1
$14.1M Sell
58,134
-1,650
-3% -$431K 0.16% 143
2019
Q4
$15.6M Sell
59,784
-933
-2% -$246K 0.13% 163
2019
Q3
$16.5M Buy
60,717
+630
+1% +$175K 0.15% 155
2019
Q2
$16.5M Sell
60,087
-2,018
-3% -$497K 0.16% 146
2019
Q1
$13.9M Buy
62,105
+165
+0.3% +$34.1K 0.14% 159
2018
Q4
$11.5M Sell
61,940
-6,125
-9% -$1.26M 0.13% 168
2018
Q3
$17M Buy
68,065
+3,920
+6% +$952K 0.15% 145
2018
Q2
$14M Hold
64,145
0.14% 161
2018
Q1
$12.3M Buy
64,145
+1,700
+3% +$314K 0.13% 174
2017
Q4
$9.77M Sell
62,445
-824
-1% -$130K 0.1% 211
2017
Q3
$9.84M Sell
63,269
-6,578
-9% -$1.04M 0.11% 203
2017
Q2
$11.3M Buy
69,847
+6,653
+11% +$1.08M 0.13% 173
2017
Q1
$9.77M Hold
63,194
0.12% 195
2016
Q4
$7.41M Sell
63,194
-5,276
-8% -$602K 0.09% 235
2016
Q3
$7.72M Hold
68,470
0.1% 223
2016
Q2
$6.36M Buy
68,470
+350
+0.5% +$30.1K 0.09% 250
2016
Q1
$5.33M Buy
68,120
+1,300
+2% +$93.6K 0.08% 278
2015
Q4
$4.87M Sell
66,820
-3,800
-5% -$271K 0.07% 285
2015
Q3
$5.24M Sell
70,620
-1,400
-2% -$100K 0.08% 255
2015
Q2
$4.62M Sell
72,020
-1,200
-2% -$83.1K 0.07% 308
2015
Q1
$5.66M Hold
73,220
0.08% 261
2014
Q4
$5.43M Sell
73,220
-200
-0.3% -$14K 0.07% 265
2014
Q3
$4.33M Sell
73,420
-600
-0.8% -$37.9K 0.06% 307
2014
Q2
$4.94M Buy
74,020
+600
+0.8% +$38.2K 0.07% 276
2014
Q1
$4.46M Sell
73,420
-6,800
-8% -$405K 0.06% 289
2013
Q4
$4.27M Hold
80,220
0.06% 296
2013
Q3
$4M Sell
80,220
-11,400
-12% -$548K 0.06% 301
2013
Q2
$4.11M Buy
+91,620
New +$4M 0.06% 279

Other funds holding IDXX

Nisa Investment Advisors's IDXX Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Idexx Laboratories (IDXX) stake by 17% in Q1 2026, selling an estimated $4.76M and leaving 36,042 shares worth $20.3M. The position accounts for 0.07% of the portfolio, ranked #162.

Nisa Investment Advisors first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.4M in Q3 2020. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Nisa Investment Advisors held 36,042 shares of Idexx Laboratories worth $20.3M as of Q1 2026.
  • Nisa Investment Advisors sold 7,427 Idexx Laboratories shares in Q1 2026, an estimated $4.76M.
  • Idexx Laboratories made up 0.07% of Nisa Investment Advisors's portfolio in Q1 2026, its #162 holding.
  • Nisa Investment Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Idexx Laboratories position peaked at $45.4M in Q3 2020.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.